Quick Takeaways: Why It Matters? This launch is Yuyu Pharma’s first real step into the US pet health market, using Amazon as a low‑barrier, high‑visibility channel to test its cat wellness offering and build brand awareness under the Mervyn’s Petcare label. If Ari’s...
Quick Takeaways: Why It Matters? PetMade is tapping the fast‑growing “wellness plus cardiology” niche in pets, using a vet‑backed CoQ10 + omega‑3 formula to position itself as a premium, preventive heart‑health brand rather than just ano...
Quick Takeaways: Why It Matters? M2 Ingredients is plugging its clinically studied, full‑spectrum mushroom portfolio into Anchor’s pet‑food customer base, effectively turning mushrooms into a ready‑to‑spec functional building block for gut, immune, and overall wellness claims i...
Quick Takeaways: Why It Matters? IFF is using PureStrong to push a dog-first probiotic paradigm—built on a single, canine-derived Limosilactobacillus reuteri strain, into a fast-growing, 3.2 billion dollar US pet supplement market that is stil...
Quick Takeaways: Why It Matters? The deal adds another science‑forward brand to epiq’s portfolio and deepens its role as a specialty distributor that can take microbiome‑based innovations from H&H/Zesty Paws into the vet channel with supply-chain and market‑access...
Quick Takeaways: Why It Matters? By adding a feline‑specific soft chew built on proprietary CBD + CBDA data, ElleVet deepens its position as a science‑led cannabinoid brand and expands use beyond dogs into a harder‑to‑treat cat population. The palatable, lo...
Quick Takeaways: Why It Matters? A-DHA-PT gives veterinary neurologists a standardized, high‑dose DHA option developed under academic supervision, potentially making nutritional add‑on therapy a more routine consideration in dogs with idiopathic epilepsy where pharmacologic con...
